Clinical, medical, and economical benefits of Point-of-care diagnosis of acute coronary syndrome, thromboembolic events, and heart failure in primary care.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000709

Enrollment

1000

Registered

2011-02-14

Start date

2006-06-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I20.0 I21 I22 I50 I26 I80.2

Interventions

Group 1: Point-of-care testing group (POCT group): before making a working diagnosis, the physicians can analyse troponin T, NT-proBNP and/or D-Dimer with a diagnostic device (Cardiac Reader, Roche D

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients (> 18 years) presenting with potentially cardiovascular chest pain or symptoms

Exclusion criteria

Exclusion criteria: Refusal of consent, presentation >5 days after symptom onset, recent anticoagulant treatment, severe renal dysfunction and cancer therapy

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy: working diagnosis vs. confirmed/Follow-up diagnosis (about 3 weeks after working diagnosis)	—

Secondary

Measure	Time frame
Resource utilisation (consultation, transport, hospitalisation) and workdays lost between baseline and follow-up	—

Countries

Switzerland

Contacts

Public ContactThomas Szucs

Director Institute of Pharmaceutical Medicine/European Center of Pharmaceutical Medicine University of Basel

thomas.szucs@unibas.ch+41 61 265 7650

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 29, 2026